The authors reported that higher levels of plasma S100A12 and the overall RAGE score were associated with shorter amputation-free survival in T2D patients, suggesting that the RAGE pathway contributed to the severity of PAD (65). The gene discussed is AGER; the disease is peripheral arterial disease.